Transfer of type II collagen‐induced arthritis from DBA/1 to severe combined immunodeficiency mice can be prevented by blockade of Mac‐1
- 1 June 1996
- journal article
- Published by Wiley in Immunology
- Vol. 88 (2) , 315-321
- https://doi.org/10.1111/j.1365-2567.1996.tb00021.x
Abstract
Collagen-induced arthritis in susceptible mice is widely accepted as an experimental model for human rheumatoid arthritis (RA). We have investigated the role of the Mac-1 integrin beta 2 in the development and maintenance of arthritis by means of in vivo administration of 5C6 monoclonal antibody (mAb) to block this receptor. Injection of a single dose of 5C6 mAb (0.5 mg, intraperitoneally) prior to the expected onset of collagen-induced arthritis in DBA/1 mice diminished the severity of subsequent disease in these animals, as assessed both clinically and histologically (P < 0.01, chi 2). In the DBA/1 to severe combined immunodeficiency (SCID) transfer model of arthritis, the incidence of clinical arthritis was significantly reduced in SCID mice receiving maintained 5C6 treatment commencing the day prior to administration of donor splenocytes. Histological evaluation of joints from animals without clinically evident arthritis confirmed the absence of an inflammatory infiltrate in 22/27 joints examined. In a minority of these joints, however, synovial hyperplasia was apparent. In contrast, delaying antibody administration until 10 days after donor spleen cell transfer failed to protect three of five SCID recipients. These results confirm a functional role for Mac-1 in the generation of collagen-induced arthritis in mice. Since mAb 5C6 is non-cytotoxic, its action must be by blockade of the interactions between Mac-1 and its natural ligand(s). Our findings support the hypothesis that cells expressing Mac-1 play an important role in the induction and maintenance of joint damage in collagen-induced arthritis.Keywords
This publication has 24 references indexed in Scilit:
- CD4+ T cells from collagen-induced arthritic mice are essential to transfer arthritis into severe combined immunodeficient miceClinical and Experimental Immunology, 1994
- CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functionsClinical and Experimental Immunology, 1993
- Generation of signals activating neutrophil functions by leukocyte integrins: LFA-1 and gp150/95, but not CR3, are able to stimulate the respiratory burst of human neutrophils.The Journal of cell biology, 1992
- Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophagesNature, 1990
- Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix proteins and CD11/CD18 integrins.The Journal of cell biology, 1989
- Relative contribution of the leukocyte molecules MO1, LFA‐1, and p150,95 (LeuM5) in adhesion of granulocytes and monocytes to vascular endothelium is tissue‐ and stimulus‐specificJournal of Cellular Physiology, 1988
- Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell recruitment in vivo.The Journal of Experimental Medicine, 1987
- Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4.The Journal of Experimental Medicine, 1985
- Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice.Journal of Clinical Investigation, 1982
- Structural studies on cartilage collagen employing limited cleavage and solubilization with pepsinBiochemistry, 1972